stoxline Quote Chart Rank Option Currency Glossary
Accuray Incorporated (ARAY)
2.54  -0.07 (-2.68%)    12-01 16:00
Open: 2.5
High: 2.6
Volume: 1,443,938
Pre. Close: 2.61
Low: 2.395
Market Cap: 247(M)
Technical analysis
2023-12-01 4:18:16 PM
Short term     
Mid term     
Targets 6-month :  3.17 1-year :  3.41
Resists First :  2.71 Second :  2.92
Pivot price 2.62
Supports First :  2.39 Second :  1.98
MAs MA(5) :  2.63 MA(20) :  2.63
MA(100) :  3.01 MA(250) :  2.99
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  45.3 D(3) :  49.4
RSI RSI(14): 43
52-week High :  4.3 Low :  1.85
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ARAY ] has closed above bottom band by 25.3%. Bollinger Bands are 39.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.72 - 2.74 2.74 - 2.75
Low: 2.56 - 2.58 2.58 - 2.59
Close: 2.58 - 2.61 2.61 - 2.63
Company Description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Headline News

Fri, 01 Dec 2023
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates -

Thu, 23 Nov 2023
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023 -

Wed, 08 Nov 2023
Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues Top - Nasdaq

Wed, 08 Nov 2023
Accuray Incorporated (NASDAQ:ARAY) Q1 2024 Earnings Call Transcript - Yahoo Finance

Tue, 07 Nov 2023
Accuray Reports Fiscal 2024 First Quarter Financial Results - PR Newswire

Mon, 06 Nov 2023
Have Insiders Sold Accuray Shares Recently? - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 97 (M)
Shares Float 87 (M)
Held by Insiders 4.8 (%)
Held by Institutions 63.3 (%)
Shares Short 5,880 (K)
Shares Short P.Month 6,050 (K)
Stock Financials
EPS -0.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.52
Profit Margin -1.5 %
Operating Margin 3.7 %
Return on Assets (ttm) 0.8 %
Return on Equity (ttm) -13.9 %
Qtrly Rev. Growth 16.7 %
Gross Profit (p.s.) 1.58
Sales Per Share 4.68
EBITDA (p.s.) 0.11
Qtrly Earnings Growth 0 %
Operating Cash Flow 7 (M)
Levered Free Cash Flow 12 (M)
Stock Valuations
PE Ratio -36.29
PEG Ratio 0.5
Price to Book value 4.79
Price to Sales 0.54
Price to Cash Flow 35.73
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android